Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation

Sponsor
TriHealth Inc. (Other)
Overall Status
Recruiting
CT.gov ID
NCT02584088
Collaborator
(none)
80
2
49.7
40
0.8

Study Details

Study Description

Brief Summary

  • The study primarily aims to evaluate the post ablative endometrium and uterus using transvaginal ultrasound to provide descriptive information as to what may be expected in the 12 months after a NovaSure ablation. Investigators believe this knowledge will help them to determine when to proceed with further evaluation postoperatively or when to counsel patients on expectant management based on ultrasonographic findings.

  • Secondary aims include correlation of ultrasonographic findings to demographic patient data.

Condition or Disease Intervention/Treatment Phase
  • Other: Ultrasound

Detailed Description

Heavy and irregular menses affects 9-14% of gynecologic patients. Surgical can be employed intervention is sought when medical management fails. Endometrial ablation or desiccation of the endometrium using minimally invasive instruments has been utilized in this scenario. The current mainstay intervention is non-resectoscopic radio frequency ablation. These procedures have high satisfaction rates (81 to 93%) similar to hysterectomy and leave up to 47% of patients amenorrheic. Post operative complications, both short and long term, and failure rates have been well studied. A limited number of studies have been performed to assess the histologic state of the post ablative endometrium and fewer assessing the radiographic appearance of the endometrium. Therefore, this current study aims to describe the ultrasonographic appearance of the post ablative endometrium and uterus.

Study Design

Study Type:
Observational
Anticipated Enrollment :
80 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
Actual Study Start Date :
Oct 11, 2016
Anticipated Primary Completion Date :
Dec 1, 2020
Anticipated Study Completion Date :
Dec 1, 2020

Outcome Measures

Primary Outcome Measures

  1. Endometrial thickness (measured using a scale) [2 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • women of premenopausal age

  • 18 years and older

  • intended ablative management of menorrhagia

Exclusion Criteria:
  • uterine cavity anatomic abnormality

  • previous uterine ablation procedure

  • previous cervical procedure

  • presence of submucosal fibroids

  • tissue diagnosis of endometrial hyperplasia/endometrial carcinoma

  • pregnancy and delivery less than 1 year before ablation.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Good Samaritan Hospital Cincinnati Ohio United States 45220
2 Bethesda North Hospital Cincinnati Ohio United States 45242

Sponsors and Collaborators

  • TriHealth Inc.

Investigators

  • Principal Investigator: Catrina Crisp, MD, MSc, TriHealth Inc.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
TriHealth Inc.
ClinicalTrials.gov Identifier:
NCT02584088
Other Study ID Numbers:
  • 15-029
First Posted:
Oct 22, 2015
Last Update Posted:
Oct 12, 2020
Last Verified:
Oct 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by TriHealth Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 12, 2020